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ABSTRACT 
The disease Urdhvagha Amlapitta is a common functional disease of 
Annavaha srotas due to irregular, improper food habits and busy stressful 
lifestyle. This disease is a constant challenge to treat because of its 
recurrence nature due to faulty dietary habits. The management of this 
disease is somewhat difficult and patients are looking with a hope 
towards Ayurveda to overcome this challenge. So, this study was 
designed as a placebo controlled double blind trial to evaluate the 
efficacy of Katuki and Sita Churna capsules in Urdhvagha Amlapitta. 30 
patients of Urdhvaga Amalpitta were selected and randomly allocated in 
two groups. Group A received Katuki and Sita capsules and group B 
received placebo capsules, both in the dose of two capsules twice daily 
before food for 30 days. It is observed that Urdhvagha Amlapitta is seen 
in middle age and most common in females. It is usually seen in those 
whose lifestyle is not fixed and having irregular food habits. All 30 
patients had completed the treatment and no adverse effects were 
reported during the treatment. After statistical analysis the inter group 
difference were insignificant in all parameters after the end of treatment 
period except Hrit/Kanta daha where in difference was slightly 
significant with more improvement in group A than the group B. By the 
overall result we can conclude that Katuki and Sita capsules are having 
significant effect in the Urdhvaga Amlapitta. 
 
INTRODUCTION 
Urdhvaga Amlapitta is a commonly 
encountering disease of Annavaha srotas (GIT) due 
to Amlaguna udrikata of Pitta and Agnidusthi.[1] In 
the advancement of busy professional and social 
life, the change in life style, diet, behavioural 
pattern, mental stress and strain; human beings are 
more prone to the disease Urdhvaga Amlapitta. 
Intake of Viruddha, Dustha, Amla, Vidahi and Pitta 
prakopaka ahara vihara and Manasika bhavas,[2] 
faulty life style, abrupt and frequent environmental 
changes, adaptation towards unwholesome foods, 
etc. significantly aggravates the disease. 
 Amlapitta may be correlated with Acid 
Reflex Syndrome which comprises of various types 
of Gastro-esophageal reflex diseases like Gastritis, 
Dyspepsia, Heartburn, Peptic ulcer, Hyperacidity, 
etc. described in Contemporary sciences.[3] 
Urdhvaga Amlapitta is a disease with varied clinical 
presentation prevalent all over the world, most 
common in western countries. GERD symptoms 
occurs at least once a month in 44%, once a week in 
20%, and daily in 7% of the adult US population and 
in India it is likely to be between 8% and 19%, 
which appears to be similar to that of the western 
countries.[4] If it is left unattended or neglected may 
result in to aggravation or may associate with other 
complication. Contemporary science subjects to 
symptomatic therapy with antacids, acid 
suppressers (H2 receptor antagonists), and proton 
pump inhibitors. Prolonged use of these medicines 
may causes ill effects like confusion, diarrhoea, 
Hypergastrinaemia, headache, skin rashes etc.[5] In 
Ayurveda the main line of treatment for Urdhvaga 
Amlapitta is Shodhana, followed by Langhana/ 
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Laghu bhojana and Agnideepana.[6] Herbal drug 
mentioned in Gada Nigraha i.e., Katuki and Sita 
(Sheetophala) is useful in Amlapitta.[7] Katuki having 
Katu Tikta rasa, Katuvipaka, Sheeta Veerya, Ruksha 
and Laghu guna, Pitta rechaka, Kaphahara and 
Deepana, Pachana karma.[8,9] Sita having Madhura 
rasa, Madhura vipaka, Sheeta veerya, Vata Pitta 
Hara.[10] 
Due to Tridosha shamaka, Agnideepaka, that 
can be easily administered, and no evidence of 
having side effects, the present clinical trial is 
undertaken to evaluate the efficacy of Katuki and 
Sita churna in Urdhvaga Amlapitta. 
Objectives of the Study 
To evaluate the efficacy of Katuki and Sita Churna 
capsules in the management of Urdhvaga Amlapitta. 
MATERIALS & METHOD 
Research Design 
A Placebo controlled double blind comparative 
clinical trial. 
Source of Data 
30 patients were selected for the clinical trial and 
15 patients were allocated randomly to Group A 
and Group B respectively. 
Method of Drug Preparation 
1. Katuki and Sita Churna capsules 
Table 1: Ingredients of Katuki and Sita capsules 
Drug Quantity 
Katuki 1 part 
Sita  1 part 
 Dried, cleaned and best quality root of 
Katuki and Sita were subjected to pulverizer to get 
fine powder separately, and mixed thoroughly both 
in equal quantity. Then the powder is filled in a 
capsules of 500mg (size no 0) under the guidance of 
Baisajya Kalpana experts S.V.M.A.M.C. Ilkal. Then 
prepared capsules are packed in a quantity of 30 
capsules in each packet. 
2. Placebo Capsules 
In a similar manner non digestible starch is 
also filled in same colored capsules in a same 
quantity as Katuki and Sita churna were filled. Then 
prepared capsules are packed in quantity of 30 
capsules in each packet. 
Blinding 
The prepared capsules were handover to 
the HOD, Department of Kaya Chikitsa. The drugs 
were blinded and labelled as trial drug 1 and trial 
drug 2 by the Department of Kayachikitsa 
S.V.M.A.M.C., Ilkal. 
 
Selection of patients 
 Patients satisfying the inclusion criteria were 
selected from OPD and IPD of R.P.K Ayurvedic 
Hospital Ilkal, irrespective of their sex, caste, 
religion, occupation and economic status. 
 The diagnosed cases of Urdhvaga Amlapitta of 
either sex between age group of 16-60 years 
were selected for the study. 
 A special clinical proforma was prepared, clinical 
evaluation of subjects were done by collection of 
data through the information obtained by 
history, physical findings and clinical 
examination. 
 Patients were included in the study after taking a 
written consent. 
Method of Collection of Data 
Patients satisfying the inclusion criteria 
were selected from OPD and IPD of R.P.K Ayurvedic 
Hospital Ilkal, irrespective of their sex, caste, 
religion, occupation and economic status and are 
randomly allocated in group A and group B 
respectively. 
Diagnostic Criteria 
The diagnosis is mainly based on the clinical 
presentation of the patient according to the 
symptoms mentioned in classical texts of Ayurveda 
such as; 
Major symptoms[11] 
1. Avipaka 
2. Tikta /Amla Udgara 
3. Hrit / Kanta daha 
4. Utkesha 
5. Chardi 
Minor symptoms 
1. Klama 
2. Gourava 
3. Aruchi 
4. Shirashoola 
The patients were diagnosed suffering from 
Urdhvaga Amlapitta, those presenting with at least 
3 of the major and 2 of the minor complaints. 
Inclusion criteria  
 Patients diagnosed as Urdhvaga Amlapitta, as 
per diagnostic criteria. 
 Patients of age between 16 - 60 years. 
 Patients willing to participate in the clinical 
trial. 
Exclusion Criteria 
 Patient with poorly controlled hypertension, 
diabetes mellitus, or patients on prolonged 
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medications with H2 blockers, antacids, 
corticosteroids, antidepressants, etc. 
 Patient suffering with Ca. stomach, 
gastric/duodenal ulcers. 
 Pregnant and puerperal women. 
 Patients with history of heamatemesis, Melina 
and other systematic disorders that may 
interfere with the clinical trial. 
Assessment of severity 
4 point scale will be used for grading the severity of 
the individual parameters and over all severity of 
the condition. 
INTERVENTION 
Two groups assigned as A and B, were treated with 
Trial drug 1 and Trial drug 2 respectively. 
During trial Period (From 1st – 30th day) 
Group A: All 15 patients received trial drug 1 
(Katuki and Sita capsules), 2 capsules (500mg each 
capsule) twice daily 15-30 minutes before food with 
luke warm water for 30 days. 
Group B: All 15 patients received trial drug 2 
(Placebo capsules), 2 capsules (500mg each 
capsule) twice daily 15-30 minutes before food with 
luke warm water for 30 days. 
Assessment Criteria 
The total effect of therapy was assessed 
considering the overall improvement in signs and 
symptoms. The obtained results were measured 
according to the grades given below: 
Table 2: Grading of assessment criteria 
S.No. Grade Percentage 
2 Marked Improvement 76 - 100 % 
3 Moderate Improvement 51 - 75 % 
4 Mild Improvement 26 - 50 % 
5 No Improvement < 25 % 
Subjective parameters  
 Assessment of the following parameters 
before and after treatment at the end of the follow 
up. 
 Avipaka 
 Tikta / Amla Udgara 
 Hrit / Kanta Daha 
 Utklesha 
 Chardi 
 Klama 
 Gourava 
 Aruchi 
 Shirashoola 
As no objective parameters are available in 
classical text, assessment was done by only 
subjective parameters. 
Table 2: Shows Grading of Subjective Parameters 
Severity  (Normal) 
Grade 0 
(Mild) 
Grade 1 
(Moderate) 
Grade 2 
(Severe) 
Grade 3 Laxanas  
Avipaka Normal or takes normal 
time to digest food. 
Takes 4-6 hr for 
digestion of food. 
Takes 6-9 hr for 
digestion of food. 
Takes more than 9 hr 
for digestion of food. 
Klama Absent For 1-2 hrs, 
immediate after 
meal. 
Till complete 
digestion of the 
food. 
Continuous irrespective 
of digestion. 
Utklesh Absent. Occasionally but 
not daily. 
Daily and after 
taking meals (1-2 
hr) 
Frequently and feels 
Amlaasyata and Amla-
gandha and reduced 
after vomiting. 
Hrut/ 
Kanta Daha 
Absent Present only after 
consumption of 
Ushna, Teekshna, 
Amla padarth. 
Present even with 
intake of routine 
meals and relieved 
only after digestion 
of food. 
Present even with 
intake of routine meals 
and relived only by 
vomiting or antacids. 
Tikta/Ama 
Udghara 
Absent. Present1-
5times/day only on 
consumption of 
Amla, Katu, Vidahi 
padarth. 
Present 6-10 
times/ day with 
normal food, 
associated with 
Hrut/ Kanta daha. 
Present more than 10 
times/day even on 
empty stomach, 
associated with Utklesh. 
Gourava Absent Occasionally feeling 
of heaviness 
Heaviness remains 
up to the Jarana 
kala only (4-6 hrs). 
Heaviness remains after 
Jarana kala also. 
Aruchi Absent. Aruchi towards Aruchi towards Aruchi towards food. 
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food, but can eat. food. But can eat 
very little forcibly. 
Forcible consumption 
leads to nausea, and 
vomiting on occasions. 
Chardhi Absent Pt vomits 1-2 times 
in a week. 
Pt vomits 3-5 times 
in a week. 
Pt vomits more than 5 
times in a week. 
Shira shoola Absent Occasional, 
not interfering the 
daily activities 
Occasional, leads to 
disturbance for 
daily activity and 
subsides only after 
rest. 
Continuous, 
Not relieved by rest and 
requires active 
medication for the pain 
relief. 
Statistical Analysis  
 Results were analyzed statistically by using Unpaired 't' test for individual group and Paired 't' test 
for comparison of both groups. The data was collected in the form of % of improvement, SD, SE, Probability 
value ('p' value) and 't' value.  
RESULT 
Statistical Analysis of all assessment criteria in Group A 
Table 3: Showing Statistical Analysis of all assessment criteria in Group A before & after treatment 
Criteria BT AT % Improvement S.D. S.E. 
t 
value 
p value 
Interpr
etation 
Avipaka 1.87±0.74 1.20±0.56 35.83 0.49 0.13 5.29 < 0.001 H. S 
T/A udgara 2.13±0.92 0.93±0.80 56.34 0.77 0.20 6.00 < 0.001 H. S 
H/K daha 2.60±063 1.27±0.70 51.15 0.49 0.13 10.58 < 0.001 H. S 
Utklesha 1.47±1.19 0.60±0.63 59.18 0.92 0.24 3.67 0.003 S 
Chhardi 0.40±0.83 0.13±0.52 67.50 0.46 0.12 2.26 0.041 S. S 
Aruchi 0.67±1.05 0.33±0.62 49.25 0.49 0.13 2.65 0.019 S. S 
Gourava 1.73±1.33 0.67±0.82 61.85 0.96 0.25 4.30 0.001 H. S 
Klama 1.73±1.16 0.87±0.92 50.29 0.74 0.19 4.52 < 0.001 H. S 
Shira shoola 0.87±0.83 0.13±0.35 83.91 0.80 0.21 3.56 0.003 S 
Statistical evaluation of all assessment criteria in group A by paired ‘t’ test shows that highly 
significant results were noticed in Avipaka, Tikta/Amla udgara, Hrut/Kantha daha, Gorava and Klama with 
‘p’ value <0.001. Significant results were noticed in Utklesha and Shirashoola with ‘p’ value <0.01 while in 
Chhardi and Aruchi slightly significant results were observed with ‘p’ value <0.05. 
Statistical Analysis of all assessment criteria in Group B 
Table 4: Showing Statistical Analysis of all assessment criteria in Group B before & after treatment 
Criteria BT AT % Improvement S.D. S.E. t value p value 
Interpre
tation 
Avipaka 1.67±0.82 1.20±0.86 28.14 0.52 0.13 3.50 0.004 S 
T/A udgara 1.93±1.10 1.13±0.99 41.45 0.77 0.20 4.00 0.001 H. S 
H/K daha 2.20±1.21 1.47±1.06 33.18 0.80 0.21 3.56 0.003 S 
Utklesha 1.80±1.01 1.00±0.76 44.44 0.68 0.17 4.58 < 0.001 H. S 
Chhardi 0.40±0.51 0.13±0.35 67.50 0.46 0.12 2.26 0.041 S. S 
Aruchi 0.40±0.63 0.13±0.35 67.50 0.46 0.12 2.26 0.019 S.S 
Gourava 1.07±1.28 0.87±1.06 18.69 0.41 0.11 1.87 0.082 N.S 
Klama 2.07±1.03 1.53±0.92 25.60 0.64 0.17 3.23 0.006 S 
Shira shoola 1.20±0.86 0.47±0.64 60.83 0.59 0.15 4.78 < 0.001 H. S 
Statistical evaluation of all assessment criteria in group B by paired ‘t’ test shows that highly 
significant results were noticed in Tikta/Amla udgara, Utklesha and Shirashoola with ‘p’ value <0.001. 
Significant results were noticed in Avipaka and Hrut/Kantha daha with ‘p’ value <0.01 while in Chhardi and 
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Aruchi slightly significant results were observed with ‘p’ value <0.05. Gourava shows insignificant result 
with ‘p’ value >0.05. 
Statistical analysis of Inter- group difference in results 
Table 5: Statistical status of inter-group difference of changes observed in assessment criteria at the 
end of treatment i.e. 31st day 
Parameters 
Mean BT-
AT of A 
Mean BT-AT 
of B 
Mean 
difference 
SE (±) 
‘t’ 
Value 
‘p’ 
Value 
Avipaka 0.67±0.49 0.47±0.52 0.20 0.183 1.090 0.285 
Tikta/Amla udgara 1.20±0.77 0.80±0.77 0.40 0.283 1.414 0.168 
Hrut/Kantha daha 1.33±0.49 0.73±0.80 0.60 0.242 2.483 0.019 
Utklesha 0.87±0.92 0.80±0.68 0.07 0.294 0.227 0.822 
Chhardi 0.27±0.46 0.27±0.46 0.00 0.167 0.00 1.000 
Aruchi 0.33±0.49 0.27±0.46 0.07 0.173 0.386 0.703 
Gourava 1.07±0.96 0.20±0.41 0.87 0.270 3.207 0.003 
Klama 0.87±0.74 0.53±0.64 0.33 0.253 1.316 0.199 
Shirashoola 0.73±0.80 0.73±0.59 0.00 0.257 0.00 1.000 
The inter group difference in results are insignificant in all parameters when analyzed by unpaired ‘t’ 
test with ‘p’ value >0.05 for all the parameters after the end of treatment period except Hrut/Kantha daha 
wherein difference was slightly significant with more improvement in group A as difference in means was 
0.60 & ‘p’ value <0.05. 
OVERALL IMPROVEMENT 
Table 6: Overall Improvement in assessment parameters of Urdhvaga Amlapitta in both groups 
Overall Improvement Group-A Group-B 
F % f % 
Marked (>75%) 01 11.11 00 0.00 
Moderate (51-75%) 05 55.56 03 33.33 
Mild (25-50%) 03 33.33 05 55.56 
No Improvement (<25%) 00 0.00 01 11.11 
Overall assessment of improvement in 
assessment parameters shows marked 
improvement in 11.11% parameters, moderate 
improvement in 55.56% parameters, mild 
improvement in 33.33% parameters in group A 
while in group B no parameter shows marked 
improvement and moderate improvement in 
33.33% parameters, mild improvement in 55.56% 
parameters was seen. 
DISCUSSION 
 Amlapitta is a dominant disorder in the 
present scenario due to faulty lifestyle and 
behavioural pattern. After a careful screening and 
analysis of etiological factors Nidana of Amlapitta is 
not only depended on Aharaja and Viharaja along 
with Manasika and Agantuja nidanas also plays 
major role in disease Amlapitta.  
 By this study we found result of all 
assessment criteria in Group A and Group B 
between Before treatment and After treatment 
showed highly significant effects in 5 parameters 
i.e., Avipaka, Tikta amla udghara, Hrit kanta Daha, 
Gaurava and Klama with Katuki and Sita capsules in 
group A and in group B, 3 parameters i.e., Tikta 
amla udghara, Utklesha, Shirashoola with Placebo 
capsules.  
 The inter group difference in results are 
insignificant in all parameters after the end of 
treatment period except Hrut/Kantha daha wherein 
difference was slightly significant with more 
improvement in group A which indicates 
confirmative evidence regarding the therapeutic 
value of Katuki and Sita capsules.  
 The present study aimed to look for an 
effective, safe and affordable treatment of 
Urdhwaga Amlapitta. However, the herbal 
combination Katuki and Sita capsules used in this 
study showed better improvement in symptoms 
when compared to placebo. This trial drug was 
found to be well tolerated with no adverse effects. 
These beneficial actions of Katuki and Sita capsules 
might be due to the properties which possess Tikta, 
Madhura rasa, Laghu Ruksha guna, Sheeta veerya, 
Katu Madhura vipaka with Deepana Pachana karma, 
Pitta rechaka and Tridosha hara properties.[12] 
Which established a significant effect on reducing 
the severity of Amlapitta symptoms. 
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CONCLUSION 
 The overall result of this study showed 
moderate improvement in group A (Katuki and Sita 
capsules) which may because of effect of drug. At 
the same time group B (Placebo capsules) showed 
mild improvement which may because of 
psychological factor. In this study most of patients 
having Madyama satwa. Charaka mentioned in 
Satwa Pareeksha that, in Madhyama satwa "Tolerate 
the pain themselves when they realize that other 
can also tolerate it, Then at time they gain strength 
from others".[10] By the same way positive 
perception of treatment by the patients in Placebo 
group obtained significant result. 
 No side effect was encountered during the 
treatment and after follow up period.  
By the overall result we can concluded that 
Katuki and Sita capsules are having significant 
effect in the Urdhvaga Amlapitta. 
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